Paris, France

Agnes Quemener

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnes Quemener. Retrieved from https://idiyas.com/inventor/agnes-quemener-os77pz0f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2001

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Agnes Quemener in Pharmaceutical Chemistry

Introduction

Agnes Quemener, a notable inventor based in Paris, France, has made significant strides in the field of pharmaceutical chemistry. With a deep focus on histamine receptors, her innovative work has led to the development of new chemical compounds that promise various therapeutic applications.

Latest Patents

quemener holds a patent for "Imidazole derivatives as histamine receptor H3 (ANT) agonists," which encompasses novel imidazole derivatives designed to act as histamine receptor H antagonists and agonists. This patent outlines the preparation and therapeutic uses of these compounds and includes a general formula representing their structure. The invention reveals methods for assessing the agonist, partial agonist, or antagonist activity of these compounds in vivo. This innovative work adds significant value to the pharmaceutical domain, particularly in drug development.

Career Highlights

Throughout her career, Agnes Quemener has developed a keen specialization in biochemical compounds. Her research has not only expanded the understanding of histamine receptors but has also contributed to potential drug formulations aimed at treating various conditions. Her dedication to innovation is evident in her patent, showcasing her role as a pioneering inventor in this scientific area.

Collaborations

Agnes has collaborated with esteemed colleagues such as Jean-Charles Schwartz and Jean-Michel Arrang, both of whom share her passion for advancing pharmaceutical science. Together, they have worked on projects that enhance the understanding of histamine receptor interactions and their implications for drug development.

Conclusion

In summary, Agnes Quemener stands out as a significant inventor in the field of pharmaceutical chemistry, with her innovative patents paving the way for advancements in drug discovery and therapeutic applications. Her contributions, supported by collaborative efforts, highlight the importance of innovation in addressing medical needs, showcasing her impact on both science and healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…